Early in mammalian eye development, VSX2, BRN3b, and RCVRN expression marks neural retina progenitors (NRPs), retinal ganglion cells (RGCs), and photoreceptors (PRs), respectively. The ability to create retinal organoids from human induced pluripotent stem cells (hiPSC) holds great potential for modeling both human retinal development and retinal disease. However, no methods allowing the simultaneous, real-time monitoring of multiple specific retinal cell types during development currently exist. Here, we describe a CRISPR/Cas9 gene editing strategy to generate a triple transgenic reporter hiPSC line (PGP1) that utilizes the endogenous VSX2, BRN3b, and RCVRN promoters to specifically express fluorescent proteins (Cerulean in NRPs, eGFP in RGCs and mCherry in PRs) without disrupting the function of the endogenous alleles. Retinal organoid formation from the PGP1 line demonstrated the ability of the edited cells to undergo normal retina development while exhibiting appropriate fluorescent protein expression consistent with the onset of NRPs, RGCs, and PRs. Organoids produced from the PGP1 line expressed transcripts consistent with the development of all major retinal cell types. The PGP1 line offers a powerful new tool to study retinal development, retinal reprogramming, and therapeutic drug screening.
INTRODUCTION
Stem cells provide multiple avenues to address irreversible vision loss associated with retinal cell death caused by trauma or by diseases including Age-Related Macular Degeneration (AMD) and glaucoma. AMD and glaucoma alone leave millions of people blind and cost billions of dollars in social welfare and lost productivity 1, 2 . Current treatments for these diseases may slow the progression of retinal degeneration, but no available treatments restore lost retinal tissue. Recent advancements in 3D-culture have led to the development of retinal organoids, that consist of all major retinal cell types from human induced pluripotent stem cells (hiPSCs) 3 . This capability means that these hiPSC-derived organoids can experimentally model normal human retina development as well as onset and progression of retinal disease. Additionally, these organoids can provide a platform to screen new drugs for the treatment or the cure of retinal disease 3, 4 . Finally, hiPSCs provide the ability to make unlimited numbers of specific retinal neurons for potential transplantation therapies.
The rapidly expanding use of hiPSCs to model retinal development and disease justifies the need for tools to monitor the appearance of specific cell types without having to interrupt the normal developmental process. CRISPR/Cas9 gene editing greatly expands the ability to insert cell-type-specific reporter genes into hiPSCs for this purpose. Although several hiPSCs with single reporter knock-ins exist [5] [6] [7] , these lines only detect terminally differentiated retinal cell types. This limits the ability to study progression of retinal development in real time. In addition, having multiple cell type reporters inserted in the same genome will permit specific cell sorting and allow for the optimization of protocols that enrich for the development of one retinal cell type over another. For example, one might need a large number of photoreceptors or ganglion cells to screen for drugs to treat AMD or glaucoma, respectively 8, 9 . To address these limitations, we utilized CRISPR/Cas9 genome editing to create a hiPSC retina reporter line to monitor the development of neural retina progenitor (NRP), retinal ganglion (RGC), and photoreceptor (PR) cells.
Several important considerations went into choosing a strategy to target NRPs, RGCs and PRs without damaging the ability of the engineered hiPSC line to undergo normal retinal development. VSX2 encodes a transcription factor that marks NRPs before they differentiate into mature retinal cell types 10 . In the mature retina, only post-mitotic bipolar cells express VSX2 [11] [12] [13] .
RGCs represent the first mature retinal neuron cell type to develop and most RGCs express the BRN3b transcription factor 12 . PRs (rods and cones) express RCVRN, a calcium binding protein important in the recovery phase of visual excitation 14 . The cell-type-specific expression pattern of these genes made them appropriate endogenous targets for the insertion of fluorescent reporter genes. Since these three genes all play an important role in retina development and/or function, the ideal reporter hiPSC line will retain the function of both alleles of all three of these genes.
Therefore, we utilized viral P2A peptides to create fusion genes between the target and the fluorescent reporter that would self-cleave upon translation 15 .
The value of a multiple-targeted retina reporter line depends on its ability to differentiate faithfully into all retinal cell types in a stereotypical fashion while simultaneously providing visible readout without the need to add dyes or to stop the developmental process. Here, we inserted a P2A:Cerulean reporter into the VSX2 locus, a P2A:eGFP reporter into the BRN3b locus and a P2A:mCherry reporter into the RCVRN locus. In each case, we used CRISPR/Cas9 genome editing to replace the stop codon of the endogenous gene with the P2A reporter.
Validation of the resultant triple transgenic hiPSC (PGP1) line came from the ability of these cells to generate retinal organoids with the appropriate expression of each fluorescent reporter gene.
RESULTS

Creation of the Neural Retina Progenitor/ Retinal Ganglion/ Photoreceptor (PGP1)
Reporter hiPSC Line by CRISPR/Cas9 Genome Editing
CRISPR/Cas9 genome editing technology provided a powerful platform to create a hiPSC line targeted with multiple fluorescent reporter genes driven by endogenous cell-typespecific promoters. In order to achieve cell-type-specific fluorescent protein expression without inactivating the targeted gene, we designed a strategy to replace the stop codon of endogenous genes with a sequence encoding a P2A peptide fused to a fluorescent reporter gene by homology directed repair (HDR, Fig. 1 A) . To facilitate the insertion of multiple different reporter genes, the HDR targeting construct for each gene contained a different antibiotic resistance cassette.
Cells nucleofected with both a CRISPR/Cas9 vector (containing the S. pyogenes Cas9 coding sequence and a sgRNA), and an HDR targeting construct were selected with the appropriate antibiotics. DNA sequence analysis of at least two PCR amplicons (see Table S1 for primer sequences) encompassing the 5' and 3' ends of the targeted modification with at least one PCR primer outside of the sequence contained in the homology arm (HA) confirmed each homologous recombination event ( Fig. 1 B-D) .
The creation of the PGP1 line involved two sequential rounds of CRISPR/Cas9 genome editing. The first step consisted of targeting the RCVRN locus in wild-type (WT) hiPSCs with the mCherry fluorescent protein followed by selection with G418 ( Fig. 1 D) . Forty-eight of the G418 resistant hiPSC clones tested by PCR analysis (blue arrows) and DNA sequencing identified three (6.25%) correctly targeted clones. Simultaneous targeting of a G418 resistant RCVRN-targeted hiPSC clone with sgRNAs and HDR targeting constructs for VSX2 and BRN3b ( Fig. 1 B, C) resulted in the selection (puromycin and blasticidin) of 144 resistant clones. Of these triple resistant clones, four (2.8%) were correctly targeted at the VSX2, BRN3b, and RCVRN, loci. Of the three triple targeted hiPSC lines isolated, we conducted our subsequent analysis on one line that we designated PGP1.
To characterize the molecular features of the PGP1 line, we used primers for PCR and DNA sequencing to analyze both alleles of the targeted genes as well as to screen for potential Cas9-generated off-target mutations. A three-primer PCR strategy, utilizing primers introduced in Fig.1 , simultaneously tested for both the targeted and WT alleles. The forward primer used for screening the 5' targeting event ( Fig. 1 ) acted as a common primer from the endogenous gene.
Two different reverse primers, one made to the fluorescent reporter gene specific for the targeted allele, and one made to the 3' untranslated region of the endogenous gene specific for the WT allele, made it possible to determine if the clone was heterozygous or homozygous for the targeting event. PCR amplification produced DNA fragments of the expected size for both WT and targeted alleles for each gene from PGP1 genomic DNA ( Fig. 2 ). Sequence analysis of the DNA band consistent with the WT allele from each target gene size failed to reveal any indel mutations at the sgRNA cut site ( Fig. S1 ). DNA sequencing facilitated the analysis of PCR fragments amplified by primers surrounding predicted high-scoring off-target sites for each sgRNA. This analysis revealed no off-target mutations in PGP1 ( Fig. S1 and Table S2 ).
Functional Analysis of the Fluorescent Reporters in the PGP1 Line
To confirm that all three fluorescent reporter genes would express appropriately during retinal differentiation, we created retinal organoids from the PGP1 hiPSCs. Retinal organoids were differentiated from PGP1 hiPSC-derived embryoid bodies as previously described 16 .
Initially, free-floating embryoids were seeded onto Matrigel-coated plates to allow for the formation of eye field domains. At day 20 (D20) of differentiation, these eye field domains expressed Cerulean but not eGFP or mCherry ( Fig. S2 ). After four weeks of differentiation, Cerulean positive retinal domains were manually detached from the Matrigel-coated plates and cultured as free-floating 3-dimensional retinal organoids. These organoids formed spherical cups after 55 days of differentiation ( Fig. S3 ). By day 55 (D55) organoids revealed widespread fluorescence of Cerulean protein, expressed from the VSX2 promoter ( Fig. 3 A) . Likewise, at D55 these organoids exhibited eGFP expression in a more limited population of cells, driven by the BRN3b promoter, and these eGFP-expressing cells preferentially localized to the interior portion of the organoids ( Fig. 3 B) . During construction of the BRN3b/eGFP targeting vector, we inserted a cell membrane signal peptide tag (GAP43 palmitoylation sequence) to drive membrane eGFP fluorescence 17 (1,080,000 total cells) were mCherry positive. We also sorted organoids from wild type hiPSCs using the same gates used for the PGP1-derived organoids and found no cells within the To validate our FACS gating and explore the nature of the sorted populations, we performed reverse transcription -quantitative PCR (RT-qPCR) analysis on sorted populations of cells. In each case, we sorted disaggregated organoids independently for each color into three separate tubes and compared cells positive for each sorted color to the population of cells that were negative for that sorted color according to our pre-established gates. Each of the three sorts was tested by RT-qPCR in triplicate, meaning that all graphical data represented nine RT-qPCR reactions. As expected, the Cerulean positive population expressed significantly more Cerulean mRNA than the Cerulean negative population ( Fig. 4 B) . Likewise, the Cerulean positive population expressed approximately 3 times more VSX2 mRNA than the Cerulean negative population ( Fig. 4 C) . The eGFP positive sorted population expressed 22 fold more eGFP mRNA and 9.1 fold more BRN3b mRNA than the eGFP negative population of cells ( Fig. 4 E, F). On D135, the mCherry positive sorted population expressed approximately 4.9 times more mCherry mRNA and 1.9 times more RCVRN mRNA than the mCherry negative sorted population ( Fig. 4 H, I ). This demonstrates that the fluorescent reporters faithfully reveal the cells expressing the gene to which they were targeted. For both VSX2 and BRN3b the large majority of expressing cells appeared in the Cerulean and eGFP positive populations, respectively. The appearance of relatively more RCVRN transcripts in the mCherry-negative population (although significantly less than RCVRN expression in the mCherry positive population) suggests that not all mCherry-expressing cells were captured within our gate.
Alternatively, it is possible that the targeted RCVRN allele expresses RCVRN and mCherry less efficiently than the non-targeted RCVRN allele.
PGP1-Derived Retina Organoids Contain All Major Retina Cell Types
A comparison of transcripts expressed by PGP1 hiPSCs at D0 of differentiation with those expressed by PGP1-derived retinal organoids at D55 revealed a marked decrease in pluripotency-related genes and a significant increase in retina differentiation-related genes.
Pluripotency transcripts for OCT4 (POU5F1) and NANOG expressed abundantly in PGP1-hiPSCs at D0 but virtually disappeared in the D55 organoids ( Fig. 5 A) . In contrast, the retinal progenitor transcripts for PAX6, SIX3, LHX2 and VSX2 increased significantly during early retinal organoid differentiation ( Fig. 5 B) . Transcripts for ganglion cells (BRN3a and BRN3b), photoreceptors (RCVRN) and retina pigment epithelium (MITF and BEST1) also increased significantly from D0 to D55 of differentiation ( Fig 
DISCUSSION
Our overall goal encompassed the creation of a hiPSC line to permit real time analysis of neural retinal cell differentiation. Here, we have described a straightforward strategy to create multiple retina cell-type-specific reporters via CRISPR/Cas9 genome editing in hiPSCs. Cell-based transplantation approaches for the treatment of glaucoma and other ocular neurodegenerative disorders already exist. For example, transplanting human neural progenitor cells into a mouse glaucoma model increased host retinal ganglion cell survival 29 . Although the transplanted cells restored some vision, the mechanism that led to vision improvement by these cells remains unclear. In the future, PGP1-derived cells will make it possible to evaluate the fate of transplanted cells in vivo. In these transplants, PGP1 progenitors, and later bipolar cells, would exhibit blue fluorescence, while ganglion cells or photoreceptors derived from the transplant would exhibit green or red fluorescence, respectively. In another study, transplantation of GFP- The PGP1 line, and subsequent hiPSC lines developed using this approach, hold great promise for studying retinal development, disease modeling, drug screening, and pre-clinical transplantation studies.
METHODS
hiPSC Culture: Human umbilical cord stem cell derived hiPSC6.2 33 (Life Technologies, A18945) were grown on Matrigel-coated (MG) plates using chemically defined Essential 8 medium (Thermo fisher, A1517001) as described previously 34 . The medium was changed daily, and cells were passaged every 3-4 days using 0.5mM EDTA in 1xDPBS without calcium and magnesium to lift cells from the tissue culture plate (Thermo fisher, 15575020).
Specific Single Guide RNA Vector (sgRNA) Design: CRISPR specific guide RNAs
(sgRNAs) ( Table S3 ) were individually cloned into a U6-driven sgRNA expression PX458 vector that includes the S. pyogenes Cas9 coding sequence (Addgene, #48138) as described 35 . To determine the Cas9 cutting efficiency of these sgRNAs, we transfected each vector into Human Embryonic Kidney (HEK293) cells. Forty-eight hours after transfection, HEK293 DNA was extracted and amplified by Q5 High-Fidelity PCR (NEB, M0494S) using primers encompassing the sgRNA recognition site. The PCR products were digested with T7 Endonuclease I (T7E1, NEB M0302S) according to the recommended protocol 36 . Successful Cas9 cleavage by sgRNAs resulted in two distinct bands in the T7E1 assay.
Homology Directed Repair (HDR) Template Generation:
To generate the HDR templates, the left and right homology arms (HA) of each locus were amplified from the WT hiPSC genomic DNA using primers listed in Table S4 . The amplified homology arms were inserted into the P2A:Cerulean.pL451; P2A:GAP43.eGFP.pL451, P2A:mCherry.pL451 vectors via Gibson Assembly (NEB 37 ). The Cerulean tag came from addgene #53749, the membrane bound form of eGFP from addgene #14757, and mCherry from addgene #26901. DNA sequencing verified the generated HDR templates following PCR amplification. Table S4 . The clones, which exhibited the expected PCR fragment sizes on each side of the HDR junctions, were validated by DNA sequencing. To generate the triple transgenic hiPSCs, a RCVRN/mCherry hiPSC clone was transfected with 1.25ug each of: the BRN3b/eGFP HDR template, the sgRNA vector to the BRN3b locus, the VSX2/Cerulean HDR template , and the sgRNA vector to the VSX2 locus using nucleofection as described above. Double antibiotic selection was performed using 100 µg/ml Blasticidin and 100 µg/ml Puromycin, and slowly increased up to 250 µg/ml of each antibiotic over the course of one week to select for Blasticidin and Puromycin resistant colonies. Resistant clones were manually picked and cultured in a 48 well plate (one clone per well). Again, DNA from each clone was extracted and screened by PCR using primers listed in Table S4 . PCR bands of the expected size were verified by DNA sequencing.
Insertion of Fluorescent Reporter Genes into Selected
Off-Target Screening:
The PGP1 clone was screened by selecting five high scoring offtarget sites for each sgRNA used according to online tools provided by Benchling 38 . Each potential sgRNA off target site listed in Table S2 (off-target score provided by Benchling) was screened by High-Fidelity PCR (Q5 NEB, M0491L) with primers listed in Table S5 and PCR products were sequenced using Eurofins Genomics tube DNA sequencing services. Each result was independently repeated five times.
3-D Retinal Organoid Generation from the PGP1 Triple Targeted Line: The PGP1
line was used to create 3-D retinal organoids as described previously using the Zhong et al., 2014 protocol with the following modifications 16 . Briefly, hiPSC were incubated in 0.5 mM EDTA/DPBS (Thermo fisher, 15575020) for 5 minutes at 37 0 C. Cells were then dissociated into small clumps and cultured in mTeSR1 medium with 10 μM ROCK inhibitor to form aggregates.
The aggregates were gradually transitioned into neural induction medium (NIM) 16 for three days (D1-3 of differentiation), then cultured in NIM from D3 to D6. On D7, the aggregates were seeded on Matrigel (hESC-qualified, Corning)-coated dishes in NIM at an approximate density of 20 aggregates per cm 2 and switched to DMEM/F12 (3:1) supplemented with 2% Gem21
NeuroPlex (without vitamin A, Gemini Bio-Products, 400-161), 1X NEAA, and 1% antibioticantimycotic (Thermo, 15240062) on D16. The medium was changed every 3 days. On the fourth week (D28) of differentiation, a cell scraper was used to detach the cells from the dishes and and the cells were transferred to petri dishes. The cells were then cultured in suspension at 37 0 C in a humidified 5% CO 2 incubator in DMEM/F12 (3:1) supplemented with 2% Gem21 NeuroPlex, 1X NEAA, and 1% antibiotic-antimycotic. Within 3-5 days, cells began forming 3-D retinal organoids. The organoids were then mechanically separated from the rest of the cells using sharpened tungsten needles under a dissecting microscope. From that point on, the medium was changed twice a week. To culture the retinal organoids long-term, the medium was supplemented with 10% fetal bovine serum (Gibco), and 2 mM GlutaMax (Invitrogen) beginning on D42. 
Reverse Transcription-PCR Analysis of Retinal
Immunofluorescence of the Retinal Organoids:
Retinal organoids were fixed with 4% paraformaldehyde (4 % PFA) for 20 minutes at room temperature. The fixed organoids were incubated in 30% sucrose overnight at 4ºC before embedding in OCT. Organoids were cryosectioned at 15 µm prior to immunofluorescence. Immunofluorescence was performed using antibodies specifically against the proteins of interest listed in Table S7 . Fluorescent images were acquired with a Nikon Eclipse 80i microscope and/or Zeiss LSM 710 Laser Scanning Confocal System. Fluorescent protein fluorescence does not survive our fixation and embedding protocol and therefore provides no interference with secondary antibody fluorescence ( Fig. S7, S8 ).
Fluorescence-Activated Cell Sorting (FACS) Analysis of the Retinal Organoids:
Thirty organoids each from D55 and D135 were incubated at 37º C in Accutase (Innovative Cell Technologies, AT104) for 20 minutes, broken down to single cells by pipetting, and filtered through a 40µm strainer (Fishersci, 22-363-547) to eliminate cell clumps, and resuspended in ice cold 5%FBS/1xHBSS (Fishersci, 14-025-092) at a concentration of 10 million cells/ml. These cells were filtered again through a second strainer (Fisher, 08-771-23) prior to sort. For the D55 sort, single cells were sorted to separate the Cerulean positive from the Cerulean negative population, and the eGFP positive from the eGFP negative population using a FACSMelody Cell Sorter (BD Biosciences). For the D135 sort, single cells were sorted to separate the mCherry positive from the mCherry negative population. The sorted populations were used to measure mRNA transcripts for Cerulean, VSX2, mCherry, RCVRN, eGFP, BRN3b, and GAPDH via RT-qPCR using the primers listed in Table S8 . Gates for sorting disaggregated retinal organoids were established in a previous experiment using HEK293 cells transiently transfected with and expression plasmid for Cerulean, eGFP, or mCherry. FACS was conducted 48 hours after transfection to determine the appropriate gates for each fluorescent protein (Fig. S4 ). In addition, organoids produced from wild-type hiPSCs were sorted using these established gates as a negative control. materials freely available upon request. 
